A Double-blind, Randomized, Comparative Trial of Itraconazole Versus Terbinafine for 2 Weeks in Tinea Capitis

Overview

Journal Br J Dermatol

Publisher Oxford University Press

Specialty Dermatology

Date 1999 Jan 20

PMID 9892912

Citations 7

Authors

M Jahangir

I Hussain

M Ul Hasan

T S Haroon

Affiliations

Soon will be listed here.

Abstract

In this randomized, double-blind study, the efficacy and safety of oral itraconazole (n = 28) and terbinafine (n = 27), each given for 2 weeks, was compared in patients with tinea capitis. Trichophyton violaceum was the major pathogen in both groups (82.1% and 88.9%, respectively). The final evaluation at week 12 showed a cure rate of 85.7% and 77.8%, respectively (P > 0.05). Adverse events noted were mild and did not warrant discontinuation of therapy.

Citing Articles

Expert Panel Review of Skin and Hair Dermatophytoses in an Era of Antifungal Resistance.

Hill R, Caplan A, Elewski B, Gold J, Lockhart S, Smith D Am J Clin Dermatol. 2024; 25(3):359-389.

PMID: 38494575 PMC: 11201321. DOI: 10.1007/s40257-024-00848-1.

Analysis of Adult Patients with Tinea Capitis in Southeastern Korea.

Lee H, Kim J, Park K, Jang Y, Lee S, Bang Y Ann Dermatol. 2021; 32(2):109-114.

PMID: 33911721 PMC: 7992550. DOI: 10.5021/ad.2020.32.2.109.

Systemic antifungal therapy for tinea capitis in children.

Chen X, Jiang X, Yang M, Gonzalez U, Lin X, Hua X Cochrane Database Syst Rev. 2016; (5):CD004685.

PMID: 27169520 PMC: 8691867. DOI: 10.1002/14651858.CD004685.pub3.

A random comparative study of terbinafine versus griseofulvin in patients with tinea capitis in Western China.

Deng S, Hu H, Abliz P, Wan Z, Wang A, Cheng W Mycopathologia. 2011; 172(5):365-72.

PMID: 21701791 DOI: 10.1007/s11046-011-9438-2.

Management of tinea capitis in childhood.

Bennassar A, Grimalt R Clin Cosmet Investig Dermatol. 2011; 3:89-98.

PMID: 21437064 PMC: 3047946. DOI: 10.2147/ccid.s7992.